Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00361140Phase 4Completed
Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)
Leukemia, LymphocyticLymphomaMyelodysplastic Syndromes+2 more
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Teresa Field, PhD, MD

H. Lee Moffitt Cancer Center and Research Institute

Very Similar
2 trials

Shared therapeutic areas:

Graft vs Host DiseaseLeukemia, LymphoidLymphoma+4 more

Worked with same sponsors:

H. Lee Moffitt Cancer Center and Research Institute
Collaborated on 2 trials
Similarity Score78%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LymphomaGraft vs Host DiseaseMyelodysplastic Syndromes+1 more
Similarity Score17%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Graft vs Host DiseaseLymphomaMyelodysplastic Syndromes
Similarity Score13%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Myelodysplastic SyndromesLymphomaMyeloproliferative Disorders
Similarity Score13%

Richard W Childs, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Graft vs Host DiseaseMyelodysplastic SyndromesMyeloproliferative Disorders
Similarity Score13%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Myelodysplastic SyndromesGraft vs Host DiseaseLymphoma
Similarity Score13%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Graft vs Host DiseaseMyelodysplastic SyndromesMyeloproliferative Disorders
Similarity Score13%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Graft vs Host DiseaseLymphomaMyeloma
Similarity Score13%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

LymphomaMyelodysplastic Syndromes
Similarity Score9%

Steven R. Alberts, MD

Mayo Clinic

Related
14 trials

Shared therapeutic areas:

LymphomaMyelodysplastic Syndromes
Similarity Score9%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00360685Not ApplicablePrincipalInvestigator

Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX

Graft-versus-host DiseaseMucositis
Completed
NCT00361140Phase 4PrincipalInvestigator

Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)

Leukemia, LymphocyticLymphomaMyelodysplastic Syndromes+2 more
Completed

All 2 trials loaded